“…Prestwich and co-workers developed covalently linked heparin-containing hyaluronic acid-based hydrogels and demonstrated efficient in vivo neovascularization due to improved loading efficiency and slow release of several heparin-binding growth factors including FGF-2, VEGF, KGF, PDGF, and TGFβ1 [20, 24–26]. More recently, heparin-containing PEG based hydrogels have been reported to act as an efficient reservoir and a tunable delivery system for various growth factors including FGF-2, VEGF, SDF-1α, and EGF, which resulted in better angiogenesis in the chicken chorioallantoic membrane (CAM), in vitro tumor, and in vivo murine kidney models [17, 18, 27, 28]. Collectively, these studies indicate that the presence of heparin in a synthetic matrix significantly enhances the encapsulation and retention of growth factors within the matrix, facilitates maintenance of their bioactivity for prolonged periods, and modulates biological response both in vitro and in vivo .…”